A multicentre, two-stage, phase 1-2 study to evaluate the safety and efficacy of intravenous GNT0006, an adeno-associated viral vector carrying the FKRP gene, in patients with FKRP-related limb-girdle muscular dystrophy (LGMD R9, formerly LGMD2I).